partnering Archives -

Roche’s Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech’s

Roche puts $70m into ArsenalBio’s programmable T-cell platform

https://pharmaphorum.com/news/roche-puts-70m-into-arsenalbios-programmable-t-cell-platform/

News/ News/ R&D

Lava fires up a $700m cancer licensing deal with Seagen

Phil Taylor immuno-oncology, Lava Therapeutics, licensing, Oncology, partnering, Seagen 0 Comment

While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting on with its

Lava fires up a $700m cancer licensing deal with Seagen

https://pharmaphorum.com/news/lava-fires-up-a-700m-cancer-licensing-deal-with-seagen/

Digital/ News/ News

Data-crunching specialist CytoReason signs $110m Pfizer alliance

Phil Taylor artificial intelligence, Biomarkers, CytoReason, digital, digital health, partnering, Pfizer 0 Comment

Three years after it started working with Pfizer, artificial intelligence-powered drug discovery specialist CytoReason has converted the relationship

Data-crunching specialist CytoReason signs $110m Pfizer alliance

https://pharmaphorum.com/news/data-crunching-specialist-cytoreason-signs-110m-pfizer-alliance/

Doctor in the hand shows the scanning of the lung .

Digital/ News/ News

Bridge Bio will use Brainomix AI in lung fibrosis trial

Phil Taylor artificial intelligence, biomarker, Brainomix, Bridge Biotherapeutics, digital, digital health, idiopathic pulmonary fibrosis, partnering, respiratory 0 Comment

Brainomix has reeled in another pharma partner for its artificial intelligence-powered biomarker software, used to track the performance

Bridge Bio will use Brainomix AI in lung fibrosis trial

https://pharmaphorum.com/news/bridge-bio-will-use-brainomix-ai-in-lung-fibrosis-trial/

News/ News/ R&D

Merck makes circular RNA play with $3.5bn Orna alliance

Phil Taylor circular RNA, Merck & Co, Oncology, Orna Therapeutics, partnering, rna, vaccines 0 Comment

Merck & Co has ramped up its involvement in the RNA category, partnering with US biotech Orna Therapeutics

Merck makes circular RNA play with $3.5bn Orna alliance

https://pharmaphorum.com/news/merck-makes-circular-rna-play-with-3-5bn-orna-alliance/

News/ News/ R&D

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Phil Taylor Bristol-Myers Squibb, deucravacitinib, GentiBio, Immunology and inflammation, inflammatory bowel disease, partnering, Treg, Zeposia 0 Comment

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for

BMS adds to IBD pipeline with $1.9bn GentiBio deal

https://pharmaphorum.com/news/bms-adds-to-ibd-pipeline-with-1-9bn-gentibio-deal/

News/ News/ R&D

Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

Phil Taylor Alzheimer's disease, Cerevance, licensing, Merck & Co, neurology, partnering 0 Comment

Merck & Co’s earlier efforts to find new therapies for Alzheimer’s disease resulted in failure, but the company

Merck swings back into Alzheimer’s with $1.1bn Cerevance alliance

https://pharmaphorum.com/news/merck-swings-back-into-alzheimers-with-1-1bn-cerevance-alliance/

News/ News/ R&D

Sosei Heptares banks $30m milestone in Neurocrine Bio alliance

Phil Taylor Karuna Therapeutics, Neurocrine Biosciences, partnering, Psychiatry, schizophrenia, Sosei Heptares 0 Comment

Sosei Heptares has taken another of its partnered G protein-coupled receptor (GPCR) programmes into mid-stage clinical trials, earning

Sosei Heptares banks $30m milestone in Neurocrine Bio alliance

https://pharmaphorum.com/news/sosei-heptares-banks-30m-milestone-in-neurocrine-bio-alliance/

Market Access/ News/ News/ News/ Oncology

Sanofi looks east with €300m Innovent cancer alliance

Phil Taylor China, immuno-oncology, Innovent, Oncology, partnering, Sanofi, sintilimab, tusamitamab ravtansine 0 Comment

Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring

Sanofi looks east with €300m Innovent cancer alliance

https://pharmaphorum.com/news/sanofi-looks-east-with-e300m-innovent-cancer-alliance/

Trending

partnering

Login